Figure 1.

Kaplan-Meier survival estimates of relapse-free survival (RFS) among 550 patients, according to tumor size, clinical estrogen receptor (ER) status, HER2 mRNA status, and histological grade. P-values were obtained from the log-rank test, and (+) denotes observations that were censored owing to loss to follow-up or on the date of last contact.

Fan et al. BMC Medical Genomics 2011 4:3   doi:10.1186/1755-8794-4-3
Download authors' original image